18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography plays a vital role in the staging and post-treatment monitoring of high-risk melanoma patients. This chapter will answer the common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in high-risk melanoma patients.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Malignant Melanoma

  • Senthil Raja,
  • Hian Liang Huang,
  • Cindy Leung,
  • Gopinath Gnanasegaran

摘要

18F-fluorodeoxyglucose (18F-FDG) positron emission tomography (PET)/computed tomography plays a vital role in the staging and post-treatment monitoring of high-risk melanoma patients. This chapter will answer the common questions about FDG PET and non-FDG PET tracers and their clinical applications, advantages, and limitations in high-risk melanoma patients.